Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intercept Pharmaceuticals
(NQ:
ICPT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Intercept Pharmaceuticals
< Previous
1
2
3
4
5
6
7
Next >
Preview: Intercept Pharmaceuticals's Earnings
March 01, 2023
Via
Benzinga
Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years
January 25, 2023
Intercept entered a deal with Amneal, likely lining up a series of new settlements.
Via
Investor's Business Daily
AT&T, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday
January 25, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 300 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
This Stock That Tripled in 2022 Could Rocket Even Higher in 2023
December 26, 2022
Potential suitors with heaps of cash to spend are lining up to get a closer look at this company's results.
Via
The Motley Fool
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Gainers
Via
Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 19, 2022
Via
Benzinga
Analyst Ratings for Intercept Pharmaceuticals
November 16, 2022
Via
Benzinga
Analyst Ratings for Intercept Pharmaceuticals
November 02, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Expert Ratings for Intercept Pharmaceuticals
November 02, 2022
Within the last quarter, Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings:
Via
Benzinga
What 6 Analyst Ratings Have To Say About Intercept Pharmaceuticals
November 02, 2022
Analysts have provided the following ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) within the last quarter:
Via
Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
November 02, 2022
Gainers
Via
Benzinga
Why Intercept Pharmaceuticals Stock Is Soaring Today
November 01, 2022
Investors are cheering the drugmaker's Q3 update.
Via
The Motley Fool
Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients
September 30, 2022
This has been a "historically challenging" population to treat.
Via
Investor's Business Daily
Gartner, Sony, Uber And Other Big Gainers From Tuesday
November 02, 2022
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Intercept Pharmaceuticals: Q3 Earnings Insights
November 01, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Outlook For Intercept Pharmaceuticals
October 31, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Citigroup To $47? Plus This Analysts Predict $95 For Papa John's
October 03, 2022
Goldman Sachs cut Citigroup Inc. (NYSE: C) price target from $54 to $47. Citigroup shares fell 0.4% to $41.51 in pre-market trading.
Via
Benzinga
Why Is Intercept Pharmaceuticals (ICPT) Stock Down 20% Today?
September 30, 2022
Market traders watched Intercept's recent clinical trial with anticipation. Unfortunately, the results fell short and ICPT stock is tanking.
Via
InvestorPlace
Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday
October 03, 2022
Goldman Sachs raised Wells Fargo & Company (NYSE: WFC) price target from $46 to $48. Goldman Sachs analyst Richard Ramsden upgraded the stock from Neutral to Buy. Wells Fargo shares rose 1.1% to $40.68...
Via
Benzinga
Nike, Lululemon, Dick's Sporting Goods And Other Big Losers From Friday
October 03, 2022
U.S. stocks closed lower with the Dow Jones dropping 500 points on Friday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Stocks Struggle For Direction As Choppy Q3 Comes To An End
September 30, 2022
Markets are having a hard time deciding how to end a dismal week (and month, and quarter).
Via
Talk Markets
FUV Stock Alert: What Is Going on With Arcimoto Today?
September 30, 2022
Arcimoto (FUV) stock is on a wild ride today after the electric vehicle (EV) company revealed plans for a strategic restructuring.
Via
InvestorPlace
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
October 03, 2022
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
Via
Benzinga
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
September 30, 2022
Gainers
Via
Benzinga
Wall Street Mixed; Dow Drops Over 50 Points
September 30, 2022
U.S. stocks traded mixed this morning, with the Dow Jones dropping more than 50 points on Friday.
Via
Benzinga
Intercept Pharmaceutical Stock Sees RS Rating Rise To 91
September 27, 2022
Intercept Pharmaceutical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
September 22, 2022
Gainers
Via
Benzinga
Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session
September 21, 2022
Gainers
Via
Benzinga
What Is Going on With Clovis Oncology (CLVS) Stock Today?
September 21, 2022
Clovis Oncology (CLVS) stock is getting a boost on Wednesday as investors react to news of it reaching a two-year clinical supply agreement.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.